Hepatocellular carcinoma cell lines (HCC, including HepG2 and Huh7) and human normal cells (HL-7702) were available from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS). HepG2 and Huh7 cells were cultured in DMEM (Biosharp; Biosharp Life Sciences) with 10%
FBS (Biosharp; Biosharp Life Sciences) at 37°C with 5% CO
2.
Cell viability was determined using a
Cell Counting Kit. HepG2 cells (2 × 10
3/well), Huh7 cells (2 × 10
3/well), and HL-7702 (2 × 10
3/well) were seeded into 96-well plates. The cells were cultured with the NPs of compounds
1 and
2 for 24 h, respectively. Cytotoxicity was evaluated using the
Cell Counting Kit-8 (CCK-8, Abbkine Scientific). CCK-8 was added to the medium and incubated with the cells for 2 h. Then, the absorbance was measured on a microplate reader. The cell viability was calculated as follows:
where A
treatment = mean absorbance of the medium from cells incubated with NPs containing complex 1 or 2 and A
control = mean absorbance of the medium incubated without NPs of non-treated cells. The half-maximal inhibitory concentration (IC
50) was calculated using SPSS 25.0 software.
The MTT assay was repeated three times.
Shi X., Gu Y., Wan C., Jiang X., Shen L., Tan L., Zhong Y, & Zou D. (2022). Two copper(II) compounds derived from tetrazole carboxylates for chemodynamic therapy against hepatocellular carcinoma cells. Frontiers in Chemistry, 10, 915247.